Raised S.B. No. 188
Session Year 2022


AN ACT REQUIRING BRAND NAME PRESCRIPTION DRUG MANUFACTURERS TO PROVIDE SAMPLES OF BRAND NAME DRUGS TO GENERIC PRESCRIPTION DRUG MANUFACTURERS.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.


Other Bills with Similar Topics